ResMed acquires Noctrix Health for $340 million
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
The therapy also delivered significant improvements in key liver enzyme markers
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
Subscribe To Our Newsletter & Stay Updated